Stifel Financial’s PRA Health Sciences, Inc. PRAH Stock Holding History

Stifel Financial’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,761	Closed	-$1.28M	–	3482
2021 Q2	$1.28M	Sell	7,761 -169	-2%	-$28.2K	﹤0.01%	1910
2021 Q1	$1.22M	Buy	+7,930	New	+$1.08M	﹤0.01%	1870
2020 Q1	–	Sell	-20,939	Closed	-$2.33M	–	3176
2019 Q4	$2.33M	Buy	20,939 +5,685	+37%	+$585K	﹤0.01%	1244
2019 Q3	$1.51M	Buy	+15,254	New	+$1.51M	﹤0.01%	1489
2019 Q2	–	Sell	-3,964	Closed	-$436K	–	3088
2019 Q1	$436K	Buy	3,964 +1,181	+42%	+$123K	﹤0.01%	2149
2018 Q4	$258K	Buy	2,783 +807	+41%	+$81.7K	﹤0.01%	2317
2018 Q3	$219K	Buy	+1,976	New	+$206K	﹤0.01%	2538

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Stifel Financial's PRAH Position: Q3 2021 in Review

Stifel Financial sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 7,761 shares — an estimated $1.28M sold.

Stifel Financial first reported a position in PRAH in Q3 2018 and held it in 7 quarters. The position peaked at $2.33M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Stifel Financial reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Stifel Financial sold 7,761 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.28M.
Stifel Financial first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 7 quarters.
Stifel Financial's PRA Health Sciences, Inc. position peaked at $2.33M in Q4 2019.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Stifel Financial's 13F filing for Q3 2021, filed 15 Nov 2021.